COMP <GO>
RCEL vs TCMD // NET PROFIT MARGIN
Avita Medical Inc. (NASDAQ) VS. Tactile Systems Technology Inc. (NASDAQ) • 15-METRIC TALLY: RCEL 2
— TCMD 7
▲ NET PROFIT MARGIN LEADER: TCMD
LAST: $16.71 (+1.27%) • MKT CAP: $516.8M
net-margins
-60.00%
LAST: $24.31 (+1.67%) • MKT CAP: $550.7M
net-margins
5.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RCEL VS. TCMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RCEL | TCMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 82.10% | 75.90% | +6.20 | RCEL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 17.10% | -52.10 | TCMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 14.9x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -6.23% | 7.34% | -13.57 | TCMD | /fcf-yield <GO> |
| Operating Margin | -59.40% | 8.90% | -68.30 | TCMD | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -60.00% | 5.80% | -65.80 | TCMD | /net-margins <GO> |
| Revenue Growth (YoY) | 11.50% | 12.50% | -1.00 | TCMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 8.38 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | TCMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.2 | 49.2 | +16.91 | RCEL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 24.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $516.8M | $550.7M | -$33.9M | TCMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RCEL REV | TCMD REV | RCEL GROSS % | TCMD GROSS % | RCEL FCF | TCMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $71.6M | $329.5M | 82.1% | 75.9% | -$32.2M | $40.4M |
| FY 2024 | $64.3M | $293.0M | 85.8% | 74.0% | -$58.1M | $38.3M |
| FY 2023 | $50.1M | $274.4M | — | — | -$38.0M | $35.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RCEL // BETA —
TCMD // BETA —